Endogenous endophthalmitis as a complication in erysipelas
Endogenous endophthalmitis is a devastating infection of the eye that leads to blindness in about two-thirds of patients. It results from the haematogenous spread of a microorganism from a focus of sepsis, mainly gastro-intestinal, genitourinary or cardiac. We describe the case of a diabetic subject...
Gespeichert in:
| Veröffentlicht in: | Annales de dermatologie et de vénéréologie 2013-11, Vol.140 (11), p.718-721 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 721 |
|---|---|
| container_issue | 11 |
| container_start_page | 718 |
| container_title | Annales de dermatologie et de vénéréologie |
| container_volume | 140 |
| creator | Paquier-Valette, C Cante, V Brassat, S Camus, M Bolac, C Guillet, G |
| description | Endogenous endophthalmitis is a devastating infection of the eye that leads to blindness in about two-thirds of patients. It results from the haematogenous spread of a microorganism from a focus of sepsis, mainly gastro-intestinal, genitourinary or cardiac.
We describe the case of a diabetic subject presenting endogenous endophthalmitis following erysipelas of the leg due to Streptococcus agalactiae. The outcome was favourable thanks to prompt initiation of appropriate antibiotic treatment.
Endogenous endophthalmitis as a complication of a skin infection is a rare entity, with only about 30 reported cases in the literature. Awareness of this condition among dermatologists would allow prompt intervention, which is essential for sparing of the patient's eyesight. |
| doi_str_mv | 10.1016/j.annder.2013.07.023 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1450182999</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1450182999</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-4cc78b55808ba947a8a6c6efa28ce41d88bde04229c90db8f98ee657c761a8503</originalsourceid><addsrcrecordid>eNo1j09LxDAUxHNQ3HX1G4j06KX1JU3SF2-yrH9gwYueS5q-ulnatDbtYb-9BVcYmDn8GGYYu-OQceD68ZjZEGoaMwE8z6DIQOQXbA1c8dToHFfsOsYjABeYqyu2ElKARjBr9rQLdf9NoZ9jQkscDtPBtp2ffEzsosT13dB6Zyffh8SHhMZT9AO1Nt6wy8a2kW7PvmFfL7vP7Vu6_3h93z7v04FLPqXSuQIrpRCwskYWFq12mhor0JHkNWJVE0ghjDNQV9gYJNKqcIXmFhXkG_bw1zuM_c9McSo7Hx21rQ20zC65VMBRGGMW9P6MzlVHdTmMvrPjqfz_m_8Cjm1XnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1450182999</pqid></control><display><type>article</type><title>Endogenous endophthalmitis as a complication in erysipelas</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Paquier-Valette, C ; Cante, V ; Brassat, S ; Camus, M ; Bolac, C ; Guillet, G</creator><creatorcontrib>Paquier-Valette, C ; Cante, V ; Brassat, S ; Camus, M ; Bolac, C ; Guillet, G</creatorcontrib><description>Endogenous endophthalmitis is a devastating infection of the eye that leads to blindness in about two-thirds of patients. It results from the haematogenous spread of a microorganism from a focus of sepsis, mainly gastro-intestinal, genitourinary or cardiac.
We describe the case of a diabetic subject presenting endogenous endophthalmitis following erysipelas of the leg due to Streptococcus agalactiae. The outcome was favourable thanks to prompt initiation of appropriate antibiotic treatment.
Endogenous endophthalmitis as a complication of a skin infection is a rare entity, with only about 30 reported cases in the literature. Awareness of this condition among dermatologists would allow prompt intervention, which is essential for sparing of the patient's eyesight.</description><identifier>ISSN: 0151-9638</identifier><identifier>DOI: 10.1016/j.annder.2013.07.023</identifier><identifier>PMID: 24206809</identifier><language>fre</language><publisher>France</publisher><subject>Antifungal Agents - therapeutic use ; Bacteremia - drug therapy ; Bacteremia - etiology ; Bacteremia - microbiology ; Ceftazidime - therapeutic use ; Diabetes Mellitus, Type 2 - complications ; Disease Susceptibility ; Drug Therapy, Combination ; Endophthalmitis - drug therapy ; Endophthalmitis - etiology ; Endophthalmitis - microbiology ; Erysipelas - complications ; Erysipelas - drug therapy ; Eye Infections, Bacterial - drug therapy ; Eye Infections, Bacterial - etiology ; Eye Infections, Bacterial - microbiology ; Humans ; Imipenem - therapeutic use ; Intertrigo - complications ; Intertrigo - drug therapy ; Leg ; Levofloxacin - therapeutic use ; Male ; Middle Aged ; Obesity - complications ; Streptococcus agalactiae - isolation & purification ; Uveitis, Anterior - drug therapy ; Uveitis, Anterior - etiology ; Uveitis, Anterior - microbiology ; Vancomycin - therapeutic use</subject><ispartof>Annales de dermatologie et de vénéréologie, 2013-11, Vol.140 (11), p.718-721</ispartof><rights>Copyright © 2013 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24206809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paquier-Valette, C</creatorcontrib><creatorcontrib>Cante, V</creatorcontrib><creatorcontrib>Brassat, S</creatorcontrib><creatorcontrib>Camus, M</creatorcontrib><creatorcontrib>Bolac, C</creatorcontrib><creatorcontrib>Guillet, G</creatorcontrib><title>Endogenous endophthalmitis as a complication in erysipelas</title><title>Annales de dermatologie et de vénéréologie</title><addtitle>Ann Dermatol Venereol</addtitle><description>Endogenous endophthalmitis is a devastating infection of the eye that leads to blindness in about two-thirds of patients. It results from the haematogenous spread of a microorganism from a focus of sepsis, mainly gastro-intestinal, genitourinary or cardiac.
We describe the case of a diabetic subject presenting endogenous endophthalmitis following erysipelas of the leg due to Streptococcus agalactiae. The outcome was favourable thanks to prompt initiation of appropriate antibiotic treatment.
Endogenous endophthalmitis as a complication of a skin infection is a rare entity, with only about 30 reported cases in the literature. Awareness of this condition among dermatologists would allow prompt intervention, which is essential for sparing of the patient's eyesight.</description><subject>Antifungal Agents - therapeutic use</subject><subject>Bacteremia - drug therapy</subject><subject>Bacteremia - etiology</subject><subject>Bacteremia - microbiology</subject><subject>Ceftazidime - therapeutic use</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Disease Susceptibility</subject><subject>Drug Therapy, Combination</subject><subject>Endophthalmitis - drug therapy</subject><subject>Endophthalmitis - etiology</subject><subject>Endophthalmitis - microbiology</subject><subject>Erysipelas - complications</subject><subject>Erysipelas - drug therapy</subject><subject>Eye Infections, Bacterial - drug therapy</subject><subject>Eye Infections, Bacterial - etiology</subject><subject>Eye Infections, Bacterial - microbiology</subject><subject>Humans</subject><subject>Imipenem - therapeutic use</subject><subject>Intertrigo - complications</subject><subject>Intertrigo - drug therapy</subject><subject>Leg</subject><subject>Levofloxacin - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Obesity - complications</subject><subject>Streptococcus agalactiae - isolation & purification</subject><subject>Uveitis, Anterior - drug therapy</subject><subject>Uveitis, Anterior - etiology</subject><subject>Uveitis, Anterior - microbiology</subject><subject>Vancomycin - therapeutic use</subject><issn>0151-9638</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j09LxDAUxHNQ3HX1G4j06KX1JU3SF2-yrH9gwYueS5q-ulnatDbtYb-9BVcYmDn8GGYYu-OQceD68ZjZEGoaMwE8z6DIQOQXbA1c8dToHFfsOsYjABeYqyu2ElKARjBr9rQLdf9NoZ9jQkscDtPBtp2ffEzsosT13dB6Zyffh8SHhMZT9AO1Nt6wy8a2kW7PvmFfL7vP7Vu6_3h93z7v04FLPqXSuQIrpRCwskYWFq12mhor0JHkNWJVE0ghjDNQV9gYJNKqcIXmFhXkG_bw1zuM_c9McSo7Hx21rQ20zC65VMBRGGMW9P6MzlVHdTmMvrPjqfz_m_8Cjm1XnA</recordid><startdate>201311</startdate><enddate>201311</enddate><creator>Paquier-Valette, C</creator><creator>Cante, V</creator><creator>Brassat, S</creator><creator>Camus, M</creator><creator>Bolac, C</creator><creator>Guillet, G</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201311</creationdate><title>Endogenous endophthalmitis as a complication in erysipelas</title><author>Paquier-Valette, C ; Cante, V ; Brassat, S ; Camus, M ; Bolac, C ; Guillet, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-4cc78b55808ba947a8a6c6efa28ce41d88bde04229c90db8f98ee657c761a8503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2013</creationdate><topic>Antifungal Agents - therapeutic use</topic><topic>Bacteremia - drug therapy</topic><topic>Bacteremia - etiology</topic><topic>Bacteremia - microbiology</topic><topic>Ceftazidime - therapeutic use</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Disease Susceptibility</topic><topic>Drug Therapy, Combination</topic><topic>Endophthalmitis - drug therapy</topic><topic>Endophthalmitis - etiology</topic><topic>Endophthalmitis - microbiology</topic><topic>Erysipelas - complications</topic><topic>Erysipelas - drug therapy</topic><topic>Eye Infections, Bacterial - drug therapy</topic><topic>Eye Infections, Bacterial - etiology</topic><topic>Eye Infections, Bacterial - microbiology</topic><topic>Humans</topic><topic>Imipenem - therapeutic use</topic><topic>Intertrigo - complications</topic><topic>Intertrigo - drug therapy</topic><topic>Leg</topic><topic>Levofloxacin - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Obesity - complications</topic><topic>Streptococcus agalactiae - isolation & purification</topic><topic>Uveitis, Anterior - drug therapy</topic><topic>Uveitis, Anterior - etiology</topic><topic>Uveitis, Anterior - microbiology</topic><topic>Vancomycin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paquier-Valette, C</creatorcontrib><creatorcontrib>Cante, V</creatorcontrib><creatorcontrib>Brassat, S</creatorcontrib><creatorcontrib>Camus, M</creatorcontrib><creatorcontrib>Bolac, C</creatorcontrib><creatorcontrib>Guillet, G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Annales de dermatologie et de vénéréologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paquier-Valette, C</au><au>Cante, V</au><au>Brassat, S</au><au>Camus, M</au><au>Bolac, C</au><au>Guillet, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endogenous endophthalmitis as a complication in erysipelas</atitle><jtitle>Annales de dermatologie et de vénéréologie</jtitle><addtitle>Ann Dermatol Venereol</addtitle><date>2013-11</date><risdate>2013</risdate><volume>140</volume><issue>11</issue><spage>718</spage><epage>721</epage><pages>718-721</pages><issn>0151-9638</issn><abstract>Endogenous endophthalmitis is a devastating infection of the eye that leads to blindness in about two-thirds of patients. It results from the haematogenous spread of a microorganism from a focus of sepsis, mainly gastro-intestinal, genitourinary or cardiac.
We describe the case of a diabetic subject presenting endogenous endophthalmitis following erysipelas of the leg due to Streptococcus agalactiae. The outcome was favourable thanks to prompt initiation of appropriate antibiotic treatment.
Endogenous endophthalmitis as a complication of a skin infection is a rare entity, with only about 30 reported cases in the literature. Awareness of this condition among dermatologists would allow prompt intervention, which is essential for sparing of the patient's eyesight.</abstract><cop>France</cop><pmid>24206809</pmid><doi>10.1016/j.annder.2013.07.023</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0151-9638 |
| ispartof | Annales de dermatologie et de vénéréologie, 2013-11, Vol.140 (11), p.718-721 |
| issn | 0151-9638 |
| language | fre |
| recordid | cdi_proquest_miscellaneous_1450182999 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Antifungal Agents - therapeutic use Bacteremia - drug therapy Bacteremia - etiology Bacteremia - microbiology Ceftazidime - therapeutic use Diabetes Mellitus, Type 2 - complications Disease Susceptibility Drug Therapy, Combination Endophthalmitis - drug therapy Endophthalmitis - etiology Endophthalmitis - microbiology Erysipelas - complications Erysipelas - drug therapy Eye Infections, Bacterial - drug therapy Eye Infections, Bacterial - etiology Eye Infections, Bacterial - microbiology Humans Imipenem - therapeutic use Intertrigo - complications Intertrigo - drug therapy Leg Levofloxacin - therapeutic use Male Middle Aged Obesity - complications Streptococcus agalactiae - isolation & purification Uveitis, Anterior - drug therapy Uveitis, Anterior - etiology Uveitis, Anterior - microbiology Vancomycin - therapeutic use |
| title | Endogenous endophthalmitis as a complication in erysipelas |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T17%3A15%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endogenous%20endophthalmitis%20as%20a%20complication%20in%20erysipelas&rft.jtitle=Annales%20de%20dermatologie%20et%20de%20v%C3%A9n%C3%A9r%C3%A9ologie&rft.au=Paquier-Valette,%20C&rft.date=2013-11&rft.volume=140&rft.issue=11&rft.spage=718&rft.epage=721&rft.pages=718-721&rft.issn=0151-9638&rft_id=info:doi/10.1016/j.annder.2013.07.023&rft_dat=%3Cproquest_pubme%3E1450182999%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1450182999&rft_id=info:pmid/24206809&rfr_iscdi=true |